TrialPloS one2016

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.

Cristiano Ferrario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.